Toll-like receptor-targeted anti-tumor therapies: Advances and challenges
Y Yang, H Li, C Fotopoulou, P Cunnea… - Frontiers in …, 2022 - frontiersin.org
Toll-like receptors (TLRs) are pattern recognition receptors, originally discovered to
stimulate innate immune reactions against microbial infection. TLRs also play essential roles …
stimulate innate immune reactions against microbial infection. TLRs also play essential roles …
Immunotherapy in HPV-related oropharyngeal cancers
L Roof, E Yilmaz - Current Treatment Options in Oncology, 2023 - Springer
Opinion statement Human papillomavirus (HPV)–related oropharyngeal squamous cell
carcinoma (OPSCC) incidence has been increasing in recent decades. Treatment of the …
carcinoma (OPSCC) incidence has been increasing in recent decades. Treatment of the …
[HTML][HTML] Small-molecule agents for cancer immunotherapy
F Wang, K Fu, Y Wang, C Pan, X Wang, Z Liu… - … Pharmaceutica Sinica B, 2023 - Elsevier
Cancer immunotherapy, exemplified by the remarkable clinical benefits of the immune
checkpoint blockade and chimeric antigen receptor T-cell therapy, is revolutionizing cancer …
checkpoint blockade and chimeric antigen receptor T-cell therapy, is revolutionizing cancer …